Watch Cymer's (Nasdaq: CYMI) earnings report to see if it can beat analyst expectations for the fifth consecutive quarter. The company will unveil its latest earnings on Thursday, July 21. Cymer, together with its wholly owned subsidiaries, is engaged in the development, manufacturing, and marketing of excimer light sources for sale to customers who manufacture photolithography tools in the semiconductor equipment industry.
What analysts say:
- Buy, sell, or hold?: Analysts are bullish on this stock with four analysts rating it as a buy and only one rating it as a sell. Analysts like Cymer better than competitor Veeco Instruments overall. Analysts' rating of Cymer has stayed constant from three months prior.
- Revenue Forecasts: On average, analysts predict $157.5 million in revenue this quarter. That would represent a rise of 19.4% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $0.71 per share. Estimates range from $0.69 to $0.75.
What our community says:
CAPS All Stars are solidly backing the stock, with 93% assigning it an "outperform" rating. The community at large backs the All Stars, with 85.4% giving it a rating of "outperform." Fools are gung-ho about Cymer, though the message boards have been quiet lately with only 47 posts in the past 30 days. Cymer's bearish CAPS rating of two out of five stars falls short of the Fool community sentiment.
Management:
Now let's look at how efficient management is at running the business. Traditionally, margins represent the efficiency with which companies capture portions of sales dollars. The following table shows gross, operating, and net margins over the past four quarters.
| Quarter | Q1 | Q4 | Q3 | Q2 |
| Gross Margin | 51.5% | 53.1% | 48.3% | 52.7% |
| Operating Margin | 23.1% | 25.3% | 21.3% | 23.7% |
| Net Margin | 18.7% | 22.4% | 14.7% | 16.1% |
For all our Cymer-specific analysis, including earnings and beyond, add Cymer to My Watchlist.
